Elastin fragmentation and atherosclerosis progression: The elastokine concept

Trends in Cardiovascular Medicine

Volumn 23, Issue 6, 2013, Pages 211-221

  Maurice, Pascal ^a   Blaise, Sébastien ^a   Gayral, Stéphanie ^b   Debelle, Laurent ^a   Laffargue, Muriel ^b   Hornebeck, William ^a   Duca, Laurent ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b Departments of Clinical Biochemistry and Sports Medicine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTASE; ELASTIN; ELASTIN RECEPTOR COMPLEX; MEMBRANE RECEPTOR; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; DISEASE COURSE; ELASTIC FIBER; ELASTOLYSIS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME DEGRADATION; FIBROBLAST; FRAGMENTATION REACTION; HUMAN; INFLAMMATORY CELL; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; VASA VASORUM;

ANIMALS; ARTERIES; ATHEROSCLEROSIS; CARDIOVASCULAR AGENTS; DISEASE PROGRESSION; ELASTIN; HUMANS; MOLECULAR TARGETED THERAPY; PANCREATIC ELASTASE; PEPTIDE FRAGMENTS; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 84880040195     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.12.004     Document Type: Review

References (72)

1. Antonicelli F., Bellon G., Debelle L., Hornebeck W. Elastin-elastases and inflamm-aging. Current Topics in Developmental Biology 2007, 79:99-155.
2. Baranek T., Debret R., Antonicelli F., Lamkhioued B., Belaaouaj A., Hornebeck W., et al. Elastin receptor (spliced galactosidase) occupancy by elastin peptides counteracts proinflammatory cytokine expression in lipopolysaccharide-stimulated human monocytes through NF-kappa B down-regulation. Journal of Immunology 2007, 179:6184-6192.
3. Barry Z.T., Platt M.O. Cathepsin S cannibalism of cathepsin K as a mechanism to reduce type I collagen degradation. Journal of Biological Chemistry 2012, 287:27723-27730.
4. Baydanoff S., Nicoloff A.G. Determination of elastin-antielastin circulating immune complexes in serum of normal subjects and atherosclerotic patients. Cor et Vasa 1991, 33:282-287.
5. Baydanoff S., Nicoloff G., Alexiev C. Age-related changes in the level of circulating elastin-derived peptides in serum from normal and atherosclerotic subjects. Atherosclerosis 1987, 66:163-168.
6. Baydanoff S., Nicoloff G., Russev T., Alexiev C. Detection of elastin-antielastin circulating immune complexes (CIC) in diabetic patients with vascular damage. Cor et Vasa 1988, 30:361-367.
7. Benagiano M., Azzurri A., Ciervo A., Amedei A., Tamburini C., Ferrari M., et al. T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:6658-6663.
8. Bhunia A.K., Arai T., Bulkley G., Chatterjee S. Lactosylceramide mediates tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 (ICAM-1) expression and the adhesion of neutrophil in human umbilical vein endothelial cells. Journal of Biological Chemistry 1998, 273:34349-34357.
9. Brassart B., Fuchs P., Huet E., Alix A.J., Wallach J., Tamburro A.M., et al. Conformational dependence of collagenase (matrix metalloproteinase-1) up-regulation by elastin peptides in cultured fibroblasts. Journal of Biological Chemistry 2001, 276:5222-5227.
10. Camps M., Ruckle T., Ji H., Ardissone V., Rintelen F., Shaw J., et al. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nature Medicine 2005, 11:936-943.
11. Cantarelli B., Duca L., Blanchevoye C., Poitevin S., Martiny L., Debelle L. Elastin peptides antagonize ceramide-induced apoptosis. FEBS Letters 2009, 583:2385-2391.
12. Debret R., Antonicelli F., Theill A., Hornebeck W., Bernard P., Guenounou M., et al. Elastin-derived peptides induce a T-helper type 1 polarization of human blood lymphocytes. Arteriosclerosis, Thrombosis, and Vascular Biology 2005, 25:1353-1358.
13. Duca L., Blanchevoye C., Cantarelli B., Ghoneim C., Dedieu S., Delacoux F., et al. The elastin receptor complex transduces signals through the catalytic activity of its Neu-1 subunit. Journal of Biological Chemistry 2007, 282:12484-12491.
14. Duca L., Floquet N., Alix A.J., Haye B., Debelle L. Elastin as a matrikine. Critical Reviews in Oncology/Hematology 2004, 49:235-244.
15. Duca L., Lambert E., Debret R., Rothhut B., Blanchevoye C., Delacoux F., et al. Elastin peptides activate extracellular signal-regulated kinase 1/2 via a Ras-independent mechanism requiring both p110gamma/Raf-1 and protein kinase A/B-Raf signaling in human skin fibroblasts. Molecular Pharmacology 2005, 67:1315-1324.
16. Fahem A., Robinet A., Cauchard J.H., Duca L., Soula-Rothhut M., Rothhut B., et al. Elastokine-mediated up-regulation of MT1-MMP is triggered by nitric oxide in endothelial cells. The International Journal of Biochemistry and Cell Biology 2008, 40:1581-1596.
17. Faury G., Ristori M.T., Verdetti J., Jacob M.P., Robert L. Effect of elastin peptides on vascular tone. Journal of Vascular Research 1995, 32:112-119.
18. Fougerat A., Gayral S., Gourdy P., Schambourg A., Ruckle T., Schwarz M.K., et al. Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes. Circulation 2008, 117:1310-1317.
19. Fougerat A., Gayral S., Malet N., Briand-Mesange F., Breton-Douillon M., Laffargue M. Phosphoinositide 3-kinases and their role in inflammation: potential clinical targets in atherosclerosis?. Clinical Science (London) 2009, 116:791-804.
20. Fougerat A., Smirnova N., Gayral S., Malet N., Hirsch E., Wymann M., et al. Key role of PI3Kgamma in monocyte chemotactic protein-1-mediated amplification of PDGF-induced aortic smooth muscle cell migration. British Journal of Pharmacology 2012, 166:1643-1653.
21. Fulop T., Larbi A., Fortun A., Robert L., Khalil A. Elastin peptides induced oxidation of LDL by phagocytic cells. Pathologie Biologie (Paris) 2005, 53:416-423.
22. Geraghty P., Rogan M.P., Greene C.M., Boxio R.M., Poiriert T., O'Mahony M., et al. Neutrophil elastase up-regulates cathepsin B and matrix metalloprotease-2 expression. Journal of Immunology 2007, 178:5871-5878.
23. Glass C.K., Witztum J.L. Atherosclerosis. the road ahead. Cell 2001, 104:503-516.
24. Hahn C.N., del Pilar Martin M., Schroder M., Vanier M.T., Hara Y., Suzuki K., et al. Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase. Human Molecular Genetics 1997, 6:205-211.
25. Heinz A., Jung M.C., Jahreis G., Rusciani A., Duca L., Debelle L., et al. The action of neutrophil serine proteases on elastin and its precursor. Biochimie 2012, 94:192-202.
26. Heinz A., Taddese S., Sippl W., Neubert R.H., Schmelzer C.E. Insights into the degradation of human elastin by matrilysin-1. Biochimie 2010, 93:187-194.
27. Hinek A., Pshezhetsky A.V., von Itzstein M., Starcher B. Lysosomal sialidase (neuraminidase-1) is targeted to the cell surface in a multiprotein complex that facilitates elastic fiber assembly. Journal of Biological Chemistry 2006, 281:3698-3710.
28. Hornebeck W., Emonard H. The cell-elastin-elastase(s) interacting triade directs elastolysis. Frontiers in Bioscience 2011, 16:707-722.
29. Itoh M., Matsuda J., Suzuki O., Ogura A., Oshima A., Tai T., et al. Development of lysosomal storage in mice with targeted disruption of the beta-galactosidase gene: a model of human G(M1)-gangliosidosis. Brain and Development 2001, 23:379-384.
30. Iwabuchi K., Prinetti A., Sonnino S., Mauri L., Kobayashi T., Ishii K., et al. Involvement of very long fatty acid-containing lactosylceramide in lactosylceramide-mediated superoxide generation and migration in neutrophils. Glycoconjugate Journal 2008, 25:357-374.
31. Johnson J.L., Devel L., Czarny B., George S.J., Jackson C.L., Rogakos V., et al. A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:528-535.
32. Kim Y.M., Haghighat L., Spiekerkoetter E., Sawada H., Alvira C.M., Wang L., et al. Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesions. American Journal of Pathology 2011, 179:1560-1572.
33. Kolodgie F.D., Gold H.K., Burke A.P., Fowler D.R., Kruth H.S., Weber D.K., et al. Intraplaque hemorrhage and progression of coronary atheroma. The New England Journal of Medicine 2003, 349:2316-2325.
34. Ledour G., Moroy G., Rouffet M., Bourguet E., Guillaume D., Decarme M., et al. Introduction of the 4- (4-bromophenyl) benzenesulfonyl group to hydrazide analogs of ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity. Bioorganic and Medicinal Chemistry 2008, 16:8745-8759.
35. Long M.M., King V.J., Prasad K.U., Freeman B.A., Urry D.W. Elastin repeat peptides as chemoattractants for bovine aortic endothelial cells. Journal of Cellular Physiology 1989, 140:512-518.
36. Lukong K.E., Seyrantepe V., Landry K., Trudel S., Ahmad A., Gahl W.A., et al. Intracellular distribution of lysosomal sialidase is controlled by the internalization signal in its cytoplasmic tail. Journal of Biological Chemistry 2001, 276:46172-46181.
37. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
38. Maquart F.X., Simeon A., Pasco S., Monboisse J.C. Regulation of cell activity by the extracellular matrix: the concept of matrikines. Journal de la Societe de Biologie 1999, 193:423-428.
39. Mithieux S.M., Weiss A.S. Elastin. Advances in Protein Chemistry 2005, 70:437-461.
40. Mochizuki S., Brassart B., Hinek A. Signaling pathways transduced through the elastin receptor facilitate proliferation of arterial smooth muscle cells. Journal of Biological Chemistry 2002, 277:44854-44863.
41. Moroy G., Alix A.J., Sapi J., Hornebeck W., Bourguet E. Neutrophil elastase as a target in lung cancer. Anti-Cancer Agents in Medicinal Chemistry 2012, 12:565-579.
42. Moroy G., Ostuni A., Pepe A., Tamburro A.M., Alix A.J., Hery-Huynh S. A proposed interaction mechanism between elastin-derived peptides and the elastin/laminin receptor-binding domain. Proteins 2009, 76:461-476.
43. Nackman G.B., Karkowski F.J., Halpern V.J., Gaetz H.P., Tilson M.D. Elastin degradation products induce adventitial angiogenesis in the Anidjar/Dobrin rat aneurysm model. Surgery 1997, 122:39-44.
44. Nicoloff G., Blazhev A., Petrova C., Christova P., Jordanova-Laleva P., Dekov D., et al. Detection of free antielastin antibodies among diabetic children. Journal of Investigative Medicine 2005, 53:128-134.
45. Nicoloff G., Petrova C., Christova P., Nikolov A. Detection of free elastin-derived peptides among diabetic children. Atherosclerosis 2007, 192:342-347.
46. Novinec M., Grass R.N., Stark W.J., Turk V., Baici A., Lenarcic B. Interaction between human cathepsins K, L, and S and elastins: mechanism of elastinolysis and inhibition by macromolecular inhibitors. Journal of Biological Chemistry 2007, 282:7893-7902.
47. Ooyama T., Fukuda K., Oda H., Nakamura H., Hikita Y. Substratum-bound elastin peptide inhibits aortic smooth muscle cell migration in vitro. Arteriosclerosis 1987, 7:593-598.
48. Patrucco E., Notte A., Barberis L., Selvetella G., Maffei A., Brancaccio M., et al. PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. Cell 2004, 118:375-387.
49. Petersen E., Wagberg F., Angquist K.A. Serum concentrations of elastin-derived peptides in patients with specific manifestations of atherosclerotic disease. European Journal of Vascular and Endovascular Surgery 2002, 24:440-444.
50. Pocza P., Suli-Vargha H., Darvas Z., Falus A. Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor. International Journal of Cancer 2008, 122:1972-1980.
51. Poggi A., Mingari M.C. Development of human NK cells from the immature cell precursors. Seminars in Immunology 1995, 7:61-66.
52. Puri K.D., Doggett T.A., Huang C.Y., Douangpanya J., Hayflick J.S., Turner M., et al. The role of endothelial PI3Kgamma activity in neutrophil trafficking. Blood 2005, 106:150-157.
53. Quillard T., Tesmenitsky Y., Croce K., Travers R., Shvartz E., Koskinas K.C., et al. Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:2464-2472.
54. Robinet A., Fahem A., Cauchard J.H., Huet E., Vincent L., Lorimier S., et al. Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP. Journal of Cell Science 2005, 118:343-356.
55. Robinet A., Millart H., Oszust F., Hornebeck W., Bellon G. Binding of elastin peptides to S-Gal protects the heart against ischemia/reperfusion injury by triggering the RISK pathway. The FASEB Journal 2007, 21:1968-1978.
56. Rusciani A., Duca L., Sartelet H., Chatron-Colliet A., Bobichon H., Ploton D., et al. Elastin peptides signaling relies on neuraminidase-1-dependent lactosylceramide generation. PLoS One 2010, 5:e14010.
57. Samokhin A.O., Wilson S., Nho B., Lizame M.L., Musenden O.E., Bromme D. Cholate-containing high-fat diet induces the formation of multinucleated giant cells in atherosclerotic plaques of apolipoprotein E-/- mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2010, 30:1166-1173.
58. Schechter I., Berger A. On the size of the active site in proteases. I. Papain. Biochemical and Biophysical Research Communications 1967, 27:157-162.
59. Senior R.M., Griffin G.L., Mecham R.P., Wrenn D.S., Prasad K.U., Urry D.W. Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. Journal of Cell Biology 1984, 99:870-874.
60. Seyrantepe V., Hinek A., Peng J., Fedjaev M., Ernest S., Kadota Y., et al. Enzymatic activity of lysosomal carboxypeptidase (cathepsin) A is required for proper elastic fiber formation and inactivation of endothelin-1. Circulation 2008, 117:1973-1981.
61. Shields K.J., Stolz D., Watkins S.C., Ahearn J.M. Complement proteins C3 and C4 bind to collagen and elastin in the vascular wall: a potential role in vascular stiffness and atherosclerosis. Clinical Translational Science 2011, 4:146-152.
62. Simionescu A., Philips K., Vyavahare N. Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells. Biochemical and Biophysical Research Communications 2005, 334:524-532.
63. Simionescu A., Simionescu D.T., Vyavahare N.R. Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-beta1: role of myofibroblasts in vascular calcification. The American Journal of Pathology 2007, 171:116-123.
64. Sluimer J.C., Daemen M.J. Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. Journal of Pathology 2009, 218:7-29.
65. Soilleux E.J., Morris L.S., Trowsdale J., Coleman N., Boyle J.J. Human atherosclerotic plaques express DC-SIGN, a novel protein found on dendritic cells and macrophages. Journal of Pathology 2002, 198:511-516.
66. Starcher B., d'Azzo A., Keller P.W., Rao G.K., Nadarajah D., Hinek A. Neuraminidase-1 is required for the normal assembly of elastic fibers. American Journal of Physiology Lung Cellular and Molecular Physiology 2008, 295:L637-L647.
67. Sun J., Sukhova G.K., Zhang J., Chen H., Sjoberg S., Libby P., et al. Cathepsin K deficiency reduces elastase perfusion-induced abdominal aortic aneurysms in mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 32:15-23.
68. Taddese S., Weiss A.S., Jahreis G., Neubert R.H., Schmelzer C.E. In vitro degradation of human tropoelastin by MMP-12 and the generation of matrikines from domain 24. Matrix Biology 2009, 28:84-91.
69. Wagenseil J.E., Mecham R.P. Elastin in large artery stiffness and hypertension. Journal of Cardiovascular Translational Research 2012, 5:264-273.
70. Weber C., Zernecke A., Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nature Reviews Immunology 2008, 8:802-815.
71. Wijkmans J., Gossen J. Inhibitors of cathepsin K: a patent review (2004-2010). Expert Opinion on Therapeutic Patents 2011, 21:1611-1629.
72. Wymann M.P., Zvelebil M., Laffargue M. Phosphoinositide 3-kinase signalling-which way to target?. Trends in Pharmacological Sciences 2003, 24:366-376.